Oct 1, 2026 06:30AM
Aug 5, 2026 07:30AM
Aug 5, 2026 07:00AM
Jul 28, 2026 04:01PM
Apr 30, 2026 07:05AM
Apr 30, 2026 07:00AM
Apr 23, 2026 07:00AM Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
Mar 2, 2026 07:21AM
Feb 26, 2026 07:14AM
Feb 26, 2026 07:00AM
Feb 19, 2026 07:00AM
Nov 16, 2025 03:00PM
Nov 4, 2025 07:04AM
Nov 4, 2025 07:00AM Kymera Therapeutics Announces Third Quarter 2025 Financial Results and Provides a Business Update
Oct 28, 2025 07:00AM
Sep 15, 2025 11:50AM
Aug 11, 2025 07:04AM
Aug 11, 2025 07:00AM
Aug 4, 2025 07:00AM
Jun 25, 2025 07:02AM
Jun 25, 2025 07:00AM Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders
May 12, 2025 06:11AM
May 9, 2025 07:21AM
May 9, 2025 07:00AM
Apr 24, 2025 07:00AM
Feb 28, 2025 10:01AM
Feb 27, 2025 07:07AM
Feb 27, 2025 07:00AM Kymera Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Feb 20, 2025 07:00AM
Nov 1, 2024 05:59AM
Oct 31, 2024 07:36AM
Oct 31, 2024 07:30AM
Oct 23, 2024 07:15AM
Aug 7, 2024 07:49AM
Aug 7, 2024 07:00AM Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
Jul 31, 2024 07:00AM
May 2, 2024 07:25AM
May 2, 2024 07:00AM
Apr 25, 2024 07:00AM
Feb 22, 2024 07:32AM
Feb 22, 2024 07:00AM
Feb 15, 2024 07:00AM Kymera Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 22
Nov 2, 2023 07:26AM
Nov 2, 2023 07:00AM
Oct 26, 2023 07:00AM
Aug 3, 2023 07:32AM
Aug 3, 2023 07:00AM
Jul 27, 2023 07:00AM
May 4, 2023 07:00AM Kymera Therapeutics Announces First Quarter 2023 Financial Results and Provides a Business Update
Apr 11, 2023 07:00AM

1,228,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All